Skip to content
The Mumbai

Strides Pharma Science Reports Q2FY27 Revenue Of ₹1,429.7 Crore, Ex-US Markets Lead Growth With 31% Jump

Strides Pharma Science Reports Q2FY27 Revenue Of ₹1,429.7 Crore, Ex-US Markets Lead Growth With 31% Jump
Photo: Free Press Journal · view original

Mumbai: Strides Pharma Science Ltd. announced its consolidated financial results for the quarter ended 30 September 2026, on Thursday. The company's Ex-US markets contributed significantly to the revenue growth. Financial Performance The company's revenue for Q2FY27 stood at ₹1,429.7 crore, up fr...

Sources and story details